SYNTHESIS OF CHEMOREVERSIBLE PRODRUGS OF ARA-C

被引：0
|
作者：
WIPF, P
SEKHAR, V
MCMASTER, JH
机构：
[1] UNIV PITTSBURGH, DEPT CHEM, PITTSBURGH, PA 15260 USA
[2] ALLEGHENY SINGER RES INST, PITTSBURGH, PA 15212 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1991年 / 202卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：52 / MEDI
相关论文
共 50 条
  • [41] THE ARA-C SYNDROME - DIRECT ENDOTHELIAL CYTOTOXICITY
    BOOGAERTS, MA
    MALBRAIN, S
    VERWILGHEN, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (03) : 423 - 423
  • [42] CLINICAL-PHARMACOLOGY OF INTERMEDIATE DOSE ARA-C (ID ARA-C) IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA IN RELAPSE
    VANPROOYEN, HC
    DEKKER, AW
    PUNT, K
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (02) : 355 - 356
  • [43] GENOTOXIC EVALUATION OF ARA-C BY MULTIPLE PARAMETERS
    HELEN, KDB
    SUBRAMANYAM, S
    MUTATION RESEARCH, 1991, 263 (03): : 185 - 196
  • [44] miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
    Haitao Bai
    Zhongwei Cao
    Chong Deng
    Lili Zhou
    Chun Wang
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 595 - 602
  • [45] CORRELATION OF CYTOSINE-ARABINOSIDE (ARA-C) PHARMACOKINETICS, ARA-C PHOSPHORYLATION, INTRACELLULAR ARA-CTP HALF-LIFE AND EFFECTS ON DNA-SYNTHESIS IN ACUTE MYELOID-LEUKEMIA
    HARRIS, AL
    GRAHAMESMITH, DG
    BRITISH JOURNAL OF CANCER, 1981, 44 (02) : 284 - 284
  • [46] miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
    Bai, Haitao
    Cao, Zhongwei
    Deng, Chong
    Zhou, Lili
    Wang, Chun
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (04) : 595 - 602
  • [47] RELATIONSHIP BETWEEN PLASMA ARA-C AND INTRACELLULAR ARA-CTP POOLS UNDER CONDITIONS OF CONTINUOUS INFUSION AND HIGH-DOSE ARA-C TREATMENT
    RUSTUM, YM
    SLOCUM, HK
    WANG, G
    BAKSHI, D
    KELLY, E
    BUSCAGLIA, D
    WRZOSEK, C
    EARLY, AP
    PREISLER, H
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 33 - 43
  • [48] BIOCHEMICAL AND IMMUNOLOGICAL STUDIES ON KINASES FOR DEOXYCYTIDINE (CDR) AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) IN NEOPLASMS SENSITIVE (P815) OR RESISTANT (P815/ARA-C) TO ARA-C
    KREIS, W
    DRAHOVSK.D
    BORBERG, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1970, 11 : 46 - &
  • [49] SYNERGY BETWEEN ARA-C AND HIGH-LEVELS OF ARA-U (HIARAU) CONTRIBUTE TO THE THERAPEUTIC EFFICACY OF HIGH-DOSE ARA-C (HIDAC)
    YANG, JL
    CHENG, E
    CAPIZZI, RL
    CHENG, YC
    KUTE, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 302 - 302
  • [50] PHARMACOKINETIC PARAMETERS OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) AND THEIR RELATIONSHIP TO INTRACELLULAR METABOLISM OF ARA-C, TOXICITY, AND RESPONSE OF PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA TREATED WITH CONVENTIONAL AND HIGH-DOSE ARA-C
    RUSTUM, YM
    RIVA, C
    PREISLER, HD
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 141 - 148
12345